Use of к-carrageenan, chitosan and Carbopol 974P in extruded and spheronized pellets that are devoid of MCC

References

• D.F. Erkoboni. Extrusion/spheronization. In: Ghebre-Sellassie I, Martin C, Eds. Pharmaceutical extrusion technology. 1st edn. New York: Marcel Dekker Inc.; 2003:277–322.
   Google Scholar
• Jain SP, Pal Singh P, Amin PD. Alternative extrusion-spheronization aids. Drug Dev Ind Pharm 2010;36:1364–76.
   PubMed Web of Science ®Google Scholar
• Carstensen JT, Osadca M, Rubin SH. Degradation mechanisms for water-soluble drugs in solid dosage forms. J Pharm Sci 1969;58:549–53.
   PubMed Web of Science ®Google Scholar
• George RC, Barbuch RJ, Huber EW, Regg BT. Investigation into the yellowing on aging of Sabril tablet cores. Drug Dev Ind Pharm 1994;20:3023–32.
   Web of Science ®Google Scholar
• Torres AI, Camacho MA. Solid state interactions of two new antineoplastic drugs (mitonafide and amonafide) and common tablet excipients in preformulation studies. Eur J Pharm Biopharm 1994;40:41–3.
   Web of Science ®Google Scholar
• Brandl M, Magill A, Rudraraju V, Gordon MS. Approaches for improving the stability of ketorolac in powder blends. J Pharm Sci 1995;84:1151–3.
   PubMed Web of Science ®Google Scholar
• Ciranni Signoretti E, Dell'utri A, De Salvo A, Donini L. Compatibility study between clenbuterol and tablet excipients using differential scanning calorimetry. Drug Dev Ind Pharm 1986;12:603–20.
   Web of Science ®Google Scholar
• Patel NK, Patel IJ, Cutie AJ, et al. The effect of selected direct compression excipients on the stability of aspirin as a model hydrolyzable drug. Drug Dev Ind Pharm 1988;14:77–98.
   Web of Science ®Google Scholar
• Basit AW, Newton JM, Lacey LF. Formulation of ranitidine pellets by extrusion-spheronization with little or no microcrystalline cellulose. Pharm Dev Technol 1999;4:499–505.
   PubMed Web of Science ®Google Scholar
• Wu Y, Levons J, Narang AS, et al. Reactive impurities in excipients: profiling, identification and mitigation of drug-excipient incompatibility. AAPS PharmSciTech 2011;12:1248–63.
   PubMed Web of Science ®Google Scholar
• Cotton ML, Wu DW, Vadas EB. Drug-excipient interaction study of enalapril maleate using thermal analysis and scanning electron microscopy. Int J Pharm 1987;40:129–42.
   Web of Science ®Google Scholar
• Okada S, Nakahara H, Isaka H. Adsorption of drugs on microcrystalline cellulose suspended in aqueous solutions. Chem Pharm Bull 1987;35:761–8.
   Web of Science ®Google Scholar
• Rivera SL, Ghodbane S. In vitro adsorption-desorption of famotidine on microcrystalline cellulose. Int J Pharm 1994;108:31–8.
   Web of Science ®Google Scholar
• Al-Nimry SS, Assaf SM, Jalal IM, Najib NM. Adsorption of ketotifen onto some pharmaceutical excipients. Int J Pharm 1997;149:115–21.
   Web of Science ®Google Scholar
• O'Connor RE, Schwartz JB. Spheronization II: drug release from drug-diluent mixtures. Drug Dev Ind Pharm 1985;11:1837–57.
   Web of Science ®Google Scholar
• Schröder M, Kleinebudde P. Development of disintegrating pellets obtained from extrusion/spheronization. Pharm Pharmacol Commun 1995;1:415–18.
   Google Scholar
• Zimm KR, Schwartz JB, O'Connor RE. Drug release from a multiparticulate pellet system. Pharm Dev Technol 1996;1:37–42.
   PubMedGoogle Scholar
• Otero-Espinar FJ, Luzardo-Alvarez A, Blanco-Méndez J. Non-MCC materials as extrusion-spheronization aids in pellet production. J Drug Del Sci Tech 2010;20:303–18.
   Web of Science ®Google Scholar
• Tripurasundari P, Prabhakar B. Review on the production of pellets via extrusion-spheronisation exclusive of microcrystalline cellulose. Int J Pharm Rev Res 2012;2:1–10.
   Google Scholar
• SR Goskonda, Upadrashta SM. Avicel RC-591/chitosan beads by extrusion-spheronization technology. Drug Dev Ind Pharm 1993;19:915–27.
   Web of Science ®Google Scholar
• Santos H, Veiga F, Pina M, et al. Physical properties of chitosan pellets produced by extrusion-spheronisation: influence of formulation variables. Int J Pharm 2002;246:153–69.
   PubMed Web of Science ®Google Scholar
• Steckel H, Mindermann-Nogly F. Production of chitosan pellets by extrusion/spheronization. Eur J Pharm Biopharm 2004;57:107–14.
   PubMed Web of Science ®Google Scholar
• Jess K, Steckel H. The extrusion and spheronization of chitosan. Pharm Technol Eur 2007;19:21–30.
   Google Scholar
• Agrawal AM, Manek RV, Kolling WM, Neau SH. Water distribution studies within microcrystalline cellulose and chitosan using differential scanning calorimetry and dynamic vapor sorption analysis. J Pharm Sci 2004;93:1766–79.
   PubMed Web of Science ®Google Scholar
• Garcia J, Ghaly ES. Evaluation of bioadhesive glipizide spheres and compacts from spheres prepared by extruder/marumerizer technique. Pharm Dev Technol 2001;6:407–17.
   PubMed Web of Science ®Google Scholar
• Mangione MR, Giacomazza D, Bulone D, et al. K(+) and Na(+) effects on the gelation properties of kappa-carrageenan. Biophys Chem 2005;113:129–35.
   PubMed Web of Science ®Google Scholar
• Bornhöft M, Thommes M, Kleinebudde P. Preliminary assessment of carrageenan as excipient for extrusion/spheronisation. Eur J Pharm Biopharm 2005;59:127–31.
   PubMed Web of Science ®Google Scholar
• Thommes M, Kleinebudde P. Use of к-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler. Eur J Pharm Biopharm 2006;63:59–67.
   PubMed Web of Science ®Google Scholar
• Thommes M, Blaschek W, Kleinebudde P. Effect of drying on extruded pellets based on kappa-carrageenan. Eur J Pharm Sci 2007;31:112–18.
   PubMed Web of Science ®Google Scholar
• Thommes M, Kleinebudde P. The behavior of different carrageenans in pelletization by extrusion/spheronization. Pharm Dev Technol 2008;13:27–35.
   PubMed Web of Science ®Google Scholar
• Thommes M, Kleinebudde P. Use of к-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type. Eur J Pharm Biopharm 2006;63:68–75.
   PubMed Web of Science ®Google Scholar
• Dukić-Ott A, Remon JP, Foreman P, Vervaet C. Immediate release of poorly soluble drugs from starch-based pellets prepared via extrusion/spheronization. Eur J Pharm Biopharm 2007;67:715–24.
   PubMed Web of Science ®Google Scholar
• Kilor V, Sapkal N, Panda B, Awari J. Improved effect of disintegrants using к-carrageenan as a pelletizing agent in the pellets of poorly soluble drugs. Int J Pharm Technol 2011;3:3186–201.
   Google Scholar
• Neau SH, Chow MY, Durrani MJ. Fabrication and characterization of extruded and spheronized beads containing Carbopol 974P, NF resin. Int J Pharm 1996;131:47–55.
   Web of Science ®Google Scholar
• Neau SH, Chow MY, Hileman GA, et al. Formulation and process considerations for beads containing carbopol 974P, NF resin made by extrusion-spheronization. Int J Pharm 2000;199:129–40.
   PubMed Web of Science ®Google Scholar
• Carbopol Resins Handbook. Cleveland, OH: BF Goodrich Company, Specialty Polymers and Chemical Division; 1993.
   Google Scholar
• Mezreb N, Charrueau C, Boy P, et al. Production of Carbopol 974P and Carbopol 971P pellets by extrusion-spheronization: optimization of the processing parameters and water content. Drug Dev Ind Pharm 2004;30:481–90.
   PubMed Web of Science ®Google Scholar
• Vila-Jato JL, Concheiro A, Seijo B, Viana B. Aging of nitrofurantoin tablets containing carbopol 934 as a binder. Int J Pharm 1986;30:229–36.
   Web of Science ®Google Scholar
• Vila-Jato JL, Concheiro A, Seijo B. Effect of aging on the bioavailability of nitrofurantoin tablets containing carbopol 934. Drug Dev Ind Pharm 1987;13:1315–27.
   Web of Science ®Google Scholar
• Funck JAB, Schwartz JB, Reilly WJ, Ghaly ES. Binder effectiveness for beads with high drug levels. Drug Dev Ind Pharm 1991;17:1143–56.
   Web of Science ®Google Scholar
• Paker-Leggs S, Neau SH. Propranolol forms affect properties of Carbopol-containing extruded-spheronized beads. Int J Pharm 2008;361:169–76.
   PubMed Web of Science ®Google Scholar
• Brazel CS, Peppas NA. Mechanisms of solute and drug transport in relaxing, swellable, hydrophilic glassy polymers. Polymer 1999;40:3383–98.
   Web of Science ®Google Scholar
• Higuchi T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963;52:1145–9.
   PubMed Web of Science ®Google Scholar
• Bommareddy GS, Paker-Leggs S, Saripella KK, Neau SH. Extruded and spheronized beads containing carbopol 974P to deliver nonelectrolytes and salts of weakly basic drugs. Int J Pharm 2006;321:62–71.
   PubMed Web of Science ®Google Scholar
• Korsmeyer RW, Peppas NA. Effect of the morphology of hydrophilic polymeric matrices on the diffusion and release of water soluble drugs. J Membr. Sci 1981;9:211–27.
   Web of Science ®Google Scholar
• Peppas NA, Sahlin JJ. A simple equation for the description of solute release. III. Coupling of diffusion and relaxation. Int J Pharm 1989;57:169–72.
   Web of Science ®Google Scholar
• Ritger PL, Peppas NA. A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J. Controlled Release 1987;5:23–36.
   Google Scholar
• Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv 1985;60:110–11.
   PubMedGoogle Scholar
• Harland RS, Gazzaniga A, Sangalli ME, et al. Drug/polymer matrix swelling and dissolution. Pharm Res 1988;5:488–94.
   PubMed Web of Science ®Google Scholar
• Kranz H, Jürgens K, Pinier M, Siepmann J. Drug release from MCC- and carrageenan-based pellets: Experiment and theory. Eur J Pharm Biopharm 2009;73:302–9.
   PubMed Web of Science ®Google Scholar
• Köster M, Thommes M. New insights into the pelletization mechanism by extrusion/spheronization. AAPS PharmSciTech 2010;11:1549–51.
   PubMed Web of Science ®Google Scholar
• Kumar MNV, Muzzarelli RAA, Muzzarelli C, et al. Chitosan chemistry and pharmaceutical perspectives. Chem Rev 2004;104:6017–84.
   PubMed Web of Science ®Google Scholar
• Sadeghi M. Synthesis of a biocopolymer carrageenan-g-poly(AAm-co-IA)/montmorilonite superabsorbent hydrogel composite. Braz J Chem Eng 2012;29:295–305.
   Web of Science ®Google Scholar
• Riley RE, Smart JD, Tsibouklis J, et al. An investigation of mucus/polymer rheological synergism using synthesized and characterized poly(acrylic acid)s. Int J Pharm 2001;217:87–100.
   PubMed Web of Science ®Google Scholar
• Tapia C, Escobar Z, Costa E, et al. Comparative studies on polyelectrolyte complexes and mixtures of chitosan–alginate and chitosan–carrageenan as prolonged diltiazem clorhydrate release systems. Eur J Pharm Biopharm 2004;57:65–75.
   PubMed Web of Science ®Google Scholar
• Tapia C, Corbalán V, Costa E, et al. Study of the release mechanism of diltiazem hydrochloride from matrices based on chitosan-alginate and chitosan-carrageenan mixtures. Biomacromolecules 2005;6:2389–95.
   PubMed Web of Science ®Google Scholar
• Piyakulawat P, Praphairaksit N, Chantarasiri N, Muangsin N. Preparation and evaluation of chitosan/carrageenan beads for controlled release of sodium diclofenac. AAPS PharmSciTech 2007;8:120–30.
   Web of Science ®Google Scholar
• Lee PI. Kinetics of drug release from hydrogel matrices. J Control Rel 1985;2:277–88.
   Google Scholar
• Maggi L, Bruni R, Conte U. High molecular weight polyethylene oxides (PEOs) as an alternative to HPMC in controlled release dosage forms. Int J Pharm 2000;195:229–38.
   PubMed Web of Science ®Google Scholar